Skip to main content
Erschienen in:

09.01.2023 | Letter to the Editor

Evaluation of Neoadjuvant Response Index (NRI) and Its Correlation with Response Evaluation Criteria in Solid Tumors (RECIST) in Locally Advanced Breast Cancer

verfasst von: Shagun Agarwal, Neeti Kapur, Poras Chaudhary

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Excerpt

Breast cancer is a site-specific cancer and is one of the major causes of cancer-related deaths among women worldwide [1, 2]. In India, breast cancer patients present at a later stage, mainly due to the absence of a screening program and general lack of awareness among the population, leading to higher rates of morbidity, and mortality [3]. Hence, neoadjuvant chemotherapy becomes essential in the management of such patients as it can downstage a tumor, facilitate R0 resection and make breast conservation feasible even in locally advanced cancers, takes care of micrometastasis in locally advancer breast cancer, provides an in vivo chemosensitivity for a particular regime of chemotherapy and an intermediate endpoint for assessing response to therapy [4]. …
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2000) (2001) Estimating the world cancer burden: Globocon. Int J Cancer 94:153–156CrossRef Parkin DM, Bray F, Ferlay J et al (2000) (2001) Estimating the world cancer burden: Globocon. Int J Cancer 94:153–156CrossRef
2.
3.
Zurück zum Zitat Raina V, Bhutani M, Bedi R et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed Raina V, Bhutani M, Bedi R et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed
4.
Zurück zum Zitat Bamal R, Chintamani TM et al (2014) Evaluation and validation of neo- adjuvant response index (NRI) and its correlation with various predictive biomarkers and RECIST in locally advanced breast cancer. Indian J surg Oncol 5:171–177CrossRefPubMedPubMedCentral Bamal R, Chintamani TM et al (2014) Evaluation and validation of neo- adjuvant response index (NRI) and its correlation with various predictive biomarkers and RECIST in locally advanced breast cancer. Indian J surg Oncol 5:171–177CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rodenhuis S, Mandjes IA, Wesseling J et al (2010) A simple system for grading the response of breast cancer to neoadjuvant chemotherapy. Ann Oncol 21:481–487CrossRefPubMed Rodenhuis S, Mandjes IA, Wesseling J et al (2010) A simple system for grading the response of breast cancer to neoadjuvant chemotherapy. Ann Oncol 21:481–487CrossRefPubMed
6.
Zurück zum Zitat Wolmark N, Wang J, Mamounas E et al (2001) Pre-operative chemotherapy in patients with operable breast cancer: nine year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30:96–102CrossRef Wolmark N, Wang J, Mamounas E et al (2001) Pre-operative chemotherapy in patients with operable breast cancer: nine year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30:96–102CrossRef
7.
Zurück zum Zitat Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414–4422CrossRefPubMed Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414–4422CrossRefPubMed
8.
Zurück zum Zitat Koh J, Kim MJ (2019) Introduction of a new staging system of breast cancer for radiologists: an emphasis on the prognostic stage. Korean J Radiol 20:69–82CrossRefPubMed Koh J, Kim MJ (2019) Introduction of a new staging system of breast cancer for radiologists: an emphasis on the prognostic stage. Korean J Radiol 20:69–82CrossRefPubMed
9.
Zurück zum Zitat Woolf DK, Padhani AR, Markis A (2015) Magnetic resonance imaging, digital mammography, and sonography: tumor characteristics and tumor biology in primary setting. JNCI Monographs 51:15–20CrossRef Woolf DK, Padhani AR, Markis A (2015) Magnetic resonance imaging, digital mammography, and sonography: tumor characteristics and tumor biology in primary setting. JNCI Monographs 51:15–20CrossRef
10.
Zurück zum Zitat NICE guideline, early and locally advanced breast cancer: diagnosis and management (2018) 6–7 NICE guideline, early and locally advanced breast cancer: diagnosis and management (2018) 6–7
11.
Zurück zum Zitat Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local- regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B- 18. Journal of clinical oncology15: 2483–2493 Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local- regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B- 18. Journal of clinical oncology15: 2483–2493
12.
Zurück zum Zitat Kuerer HM, Newman LA, Smith TL et al (1999) Clinical course of breast cancer patients with complete pathologic primary tumour and axillary lymph node response to doxorubicin- based neoadjuvant chemotherapy. J Clin Oncol 17:460–469CrossRefPubMed Kuerer HM, Newman LA, Smith TL et al (1999) Clinical course of breast cancer patients with complete pathologic primary tumour and axillary lymph node response to doxorubicin- based neoadjuvant chemotherapy. J Clin Oncol 17:460–469CrossRefPubMed
13.
Zurück zum Zitat Jeruss JS, Mittendorf EA, Tucker SL et al (2008) Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant chemotherapy. J Clin Oncol 26:246–252CrossRefPubMed Jeruss JS, Mittendorf EA, Tucker SL et al (2008) Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant chemotherapy. J Clin Oncol 26:246–252CrossRefPubMed
14.
Zurück zum Zitat Hennesey BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304–9311CrossRef Hennesey BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304–9311CrossRef
Metadaten
Titel
Evaluation of Neoadjuvant Response Index (NRI) and Its Correlation with Response Evaluation Criteria in Solid Tumors (RECIST) in Locally Advanced Breast Cancer
verfasst von
Shagun Agarwal
Neeti Kapur
Poras Chaudhary
Publikationsdatum
09.01.2023
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 2/2023
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-022-01697-2

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.